These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25194722)

  • 41. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
    No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
    Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke.
    Nathaniel TI; Cochran T; Chaves J; Fulmer E; Sosa C; Yi S; Fredwall M; Sternberg S; Blackhurst D; Nelson A; Leacock R
    Brain Inj; 2016; 30(10):1261-5. PubMed ID: 27484159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-hospital delay in the use of intravenous rt-PA for acute ischemic stroke in Japan.
    Inatomi Y; Yonehara T; Hashimoto Y; Hirano T; Uchino M
    J Neurol Sci; 2008 Jul; 270(1-2):127-32. PubMed ID: 18395754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry.
    Koga M; Kimura K; Shibazaki K; Shiokawa Y; Nakagawara J; Furui E; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Naganuma M; Nezu T; Maeda K; Minematsu K; Toyoda K
    J Neurol Sci; 2011 Jul; 306(1-2):49-53. PubMed ID: 21492878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke.
    Nogueira RG; Yoo AJ; Masrur S; Batista LM; Hakimelahi R; Hirsch JA; Schwamm LH
    J Neurointerv Surg; 2013 Jul; 5(4):298-301. PubMed ID: 22705875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke.
    Kleindorfer D; Xu Y; Moomaw CJ; Khatri P; Adeoye O; Hornung R
    Stroke; 2009 Nov; 40(11):3580-4. PubMed ID: 19797701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Association between t-PA Administration and In-Hospital Mortality following Acute Ischemic Stroke in Puerto Rican Patients.
    Shah K; Kohrman S; Alkhatib S; González J; Santiago F; Varella M; Zevallos J
    P R Health Sci J; 2016 Dec; 35(4):215-219. PubMed ID: 27898168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telestroke in South Carolina.
    Lazaridis C; DeSantis SM; Jauch EC; Adams RJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):946-50. PubMed ID: 22196873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.
    Brown DL; Barsan WG; Lisabeth LD; Gallery ME; Morgenstern LB
    Ann Emerg Med; 2005 Jul; 46(1):56-60. PubMed ID: 15988427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
    Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P
    J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
    N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.
    Ji B; Zhou F; Han L; Yang J; Fan H; Li S; Li J; Zhang X; Wang X; Chen X; Xu Y
    Transl Stroke Res; 2017 Aug; 8(4):334-340. PubMed ID: 28243834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Joint commission primary stroke centers utilize more rt-PA in the nationwide inpatient sample.
    Mullen MT; Kasner SE; Kallan MJ; Kleindorfer DO; Albright KC; Carr BG
    J Am Heart Assoc; 2013 Mar; 2(2):e000071. PubMed ID: 23537806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy of First Recorded "Last Known Normal" Times of Stroke Code Patients.
    Spokoyny I; Raman R; Ernstrom K; Kim AJ; Meyer BC; Karanjia NP
    J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):2467-73. PubMed ID: 26341734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute stroke reperfusion therapy trends in the expanded treatment window era.
    Asaithambi G; Tong X; George MG; Tsai AW; Peacock JM; Luepker RV; Lakshminarayan K
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2316-21. PubMed ID: 25156783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of survival and hyperthermia after rt-PA for ischemic stroke.
    Ueno T; Nishijima H; Hikichi H; Haga R; Arai A; Suzuki C; Nunomura JI; Tomiyama M
    Acta Neurol Scand; 2018 Dec; 138(6):574-578. PubMed ID: 30091238
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Recombinant tissue plasminogen activator therapy for acute ischemic stroke in older patients].
    Arai N; Deguchi I; Hayashi T; Tanahashi N; Takao M
    Nihon Ronen Igakkai Zasshi; 2018; 55(4):632-639. PubMed ID: 30542029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.